|
π
|
KRAS Mutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in NonβSmall-Cell Lung Cancer
9 auth.
E. Massarelli,
M. Varella-Garcia,
Ximing Tang,
A. C. Xavier,
N. Ozburn,
Diane D. Liu,
...
B. Bekele,
R. Herbst,
I. Wistuba
|
9 |
2007 |
9
π
|
|
π
|
Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small-cell lung cancer.
20 auth.
R. Herbst,
David H. Johnson,
E. Mininberg,
D. Carbone,
T. Henderson,
Edward S. Kim,
G. Blumenschein,
Jack J. Lee,
Diane D. Liu,
M. Truong,
...
W. Hong,
H. Tran,
A. Tsao,
D. Xie,
D. Ramies,
R. Mass,
S. Seshagiri,
D. Eberhard,
S. Kelley,
A. Sandler
|
9 |
2005 |
9
π
|
|
π
|
Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.
10 auth.
J. Soria,
Ho-Yyoung Lee,
Janet I. Lee,
Luo-nan Wang,
J. Issa,
B. Kemp,
...
Diane D. Liu,
J. Kurie,
L. Mao,
F. Khuri
|
8 |
2002 |
8
π
|
|
π
|
Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer.
10 auth.
S. Temam,
H. Kawaguchi,
A. El-Naggar,
J. Jelinek,
Hongli Tang,
Diane D. Liu,
...
W. Lang,
J. Issa,
J. Lee,
L. Mao
|
8 |
2007 |
8
π
|
|
π
|
Overexpression of podoplanin in oral cancer and its association with poor clinical outcome
7 auth.
P. Yuan,
S. Temam,
A. El-Naggar,
Xian Zhou,
Diane D. Liu,
J. Lee,
...
L. Mao
|
8 |
2006 |
8
π
|
|
π
|
Phase II Randomized, Placebo-Controlled Trial of Green Tea Extract in Patients with High-Risk Oral Premalignant Lesions
13 auth.
A. Tsao,
Diane D. Liu,
Jack W. Martin,
Ximing Tang,
J. Lee,
A. El-Naggar,
I. Wistuba,
K. Culotta,
L. Mao,
A. Gillenwater,
...
Y. Sagesaka,
W. Hong,
V. Papadimitrakopoulou
|
7 |
2009 |
7
π
|
|
π
|
A retrospective analysis of the outcome of patients who have received two prior chemotherapy regimens including platinum and docetaxel for recurrent non-small-cell lung cancer.
10 auth.
E. Massarelli,
F. AndrΓ©,
Diane D. Liu,
J. Lee,
M. Wolf,
A. Fandi,
...
J. Ochs,
T. Chevalier,
F. Fossella,
R. Herbst
|
7 |
2003 |
7
π
|
|
π
|
miR-200 Inhibits Lung Adenocarcinoma Cell Invasion and Metastasis by Targeting Flt1/VEGFR1
13 auth.
Jonathon D. Roybal,
Y. Zang,
YoungβHo Ahn,
Yanan Yang,
D. Gibbons,
Brandi N. Baird,
Cristina A Alvarez,
Nishan Thilaganathan,
Diane D. Liu,
P. Saintigny,
...
J. Heymach,
C. Creighton,
J. Kurie
|
7 |
2010 |
7
π
|
|
π
|
Nuclear factorβΞΊB (nfβΞΊB) is frequently expressed in lung cancer and preneoplastic lesions
9 auth.
Ximing Tang,
Diane D. Liu,
S. Shishodia,
N. Ozburn,
C. Behrens,
J. Lee,
...
W. Hong,
B. Aggarwal,
I. Wistuba
|
7 |
2006 |
7
π
|
|
π
|
Response to neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers: a single-institution experience.
11 auth.
B. Arun,
S. Bayraktar,
Diane D. Liu,
A. G. Gutierrez Barrera,
D. Atchley,
L. Pusztai,
...
J. Litton,
V. Valero,
F. Meric-Bernstam,
G. Hortobagyi,
C. Albarracin
|
7 |
2011 |
7
π
|
|
π
|
Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial
20 auth.
D. Hui,
S. Frisbee-Hume,
A. Wilson,
S. Dibaj,
Thuc Nguyen,
M. D. L. De La Cruz,
P. Walker,
D. Zhukovsky,
M. Delgado-Guay,
Marieberta Vidal,
...
D. Epner,
Akhila Reddy,
Kimerson Tanco,
Janet L. Williams,
Stacy Hall,
Diane D. Liu,
K. Hess,
Sapna Amin,
W. Breitbart,
E. Bruera
|
7 |
2017 |
7
π
|
